Related Experiment Video
Updated: May 18, 2026

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
The great escape: microbiotal LPS takes a toll on the liver
1Emory Vaccine Center, Emory University, 954 Gatewood Road, Room 2028, Atlanta, GA 30329, USA. david.weiss@emory.edu
Abstract:
The interaction between the intestinal microbiota and host is much more complex than previously appreciated, and we are now learning that it can have an impact on extraintestinal human diseases. In this issue of the journal (beginning on page 1090), Lin and colleagues present important data linking the microbiota, lipopolysaccharide (LPS), and toll-like receptor (TLR)4 with hepatitis in a mouse model. These provocative results and those from other recent studies highlight the microbiota as a potential target for therapeutic intervention in several liver diseases.
Insights
The gut microbiota influences liver health. Researchers found a link between gut bacteria, lipopolysaccharide (LPS), and toll-like receptor 4 (TLR4) in causing hepatitis in mice, suggesting new therapeutic targets.
Area of Science:
- Microbiology
- Immunology
- Hepatology
Background:
- The gut microbiota's role in host health extends beyond the intestines.
- Emerging evidence suggests microbial influence on extraintestinal diseases, including liver conditions.
Purpose of the Study:
- To investigate the connection between the intestinal microbiota, lipopolysaccharide (LPS), and toll-like receptor 4 (TLR4) in the context of hepatitis.
- To explore the microbiota as a potential therapeutic target for liver diseases.
Main Methods:
- Utilized a mouse model to study hepatitis.
- Examined the interplay between gut microbiota composition, LPS levels, and TLR4 activation.
Main Results:
- Demonstrated a significant link between the gut microbiota, LPS, and TLR4 activation in a mouse model of hepatitis.
- Provided data supporting the role of these factors in the pathogenesis of liver inflammation.
Conclusions:
- The gut microbiota, LPS, and TLR4 are implicated in hepatitis development.
- These findings highlight the potential of targeting the microbiota for therapeutic interventions in liver diseases.
Related Concept Videos
Hepatic Encephalopathy
Microbiota of the Large Intestine
Microbes in the Production of Fermented Foods
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Microbiota of the Stomach and Small Intestine
Microbial Interactions: Parasitism
